McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies
The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients.
Healthcare distributor and services company McKesson (NYSEMCK) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 17.8% year on year to $95.29 billion. Its non-GAAP profit of $8.03 per share was in line with analysts’ consensus estimates.
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential.
After Wednesday’s “everything rally” spurred by the election results, investors took a less euphoric approach on Thursday ahead of the Federal Open Market Committee (FOMC) meeting. The Fed is widely expected to cut interest rates by 25 basis points, bringing them to a range of 4.5%-4.75%, following a previous 50-basis-point cut in September.
